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A 76 year-old male farmer sought medical
attention for a large growth on the left side of the
face in February 2001. The painless swelling had
gradually increased in size over a period in excess
of 30 years. Examination showed the swelling to be
related to the left side parotid gland and was oval
in shape. The growth measured 20 cm · 30 cm in
dimensions and was firm in consistency (Fig. 1). It
was attached to the deeper structures, but mo-
vable. Venous engorgement was evident but facial
nerve palsy was not observed.
The lesion was clinically diagnosed as a benign
tumour arising in the parotid gland and fine needle
aspiration cytology diagnosed the lesion as a* Corresponding author. Tel.: +94-81-2387500; fax: +94-81-
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sequently excised under general anaesthesia along
with total parotidectomy of the left side parotid
gland, with preservation of the facial nerve.
One week post-operatively, significant left side
facial nerve weakness was observed. One month
post-operatively, the facial nerve weakness had
improved 90% and one year post operatively, no
facial nerve weakness was observed and no local
recurrences were observed. The patient is re-
viewed annually and has no complications or
recurrences thus far.
Macroscopically, the excised specimen was
ovoid in shape and 20 cm · 14 cm · 12 cm in
dimensions and weighed 3.5 kg.
Microscopically, the tumour was composed of
strands and islands of epithelial cells arranged in a
myxochondroid stroma. Some areas showed solid
sheets of epithelial cells. Ductal differentiation
was frequent (Fig. 2). There was no evidenceved.
Figure 2 Photomicrograph to show strands and islands
of epithelial cells arranged in a myxochondroid stroma
with frequent ductal differentiation (haematoxylin and
eosin stain· 4).
Figure 1 Clinical Photograph to show an oval shaped
large swelling in relation to the left side parotid gland,
20 cm · 30 cm in dimensions and with venous engorge-
ment in a 70-year-old male patient.
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a PA.Discussion
PAs are the most common salivary gland tu-
mours, accounting for 45–74% of all salivary gland
tumours.1 They occur most frequently in the par-
otid gland1 and are the most common parotid gland
tumours, accounting for a majority of parotid
masses2 and 65% of all neoplasms arising in the
parotid glands.3 They typically present in the lower
pole and superficial (lateral) lobe of the parotid
gland.1 Though localization in the deep lobe is
rare, approximately 10% of all parotid PAs are
thought to originate in the deep lobe of the gland4and can expand intraorally into the para pharyn-
geal space.1 The submandibular gland and minor
salivary glands, particularly minor salivary glands
of the palate, buccal mucosa and upper lip are
frequently affected sites as well.1 PAs usually
present as slow growing asymptomatic discrete
swellings, which gradually increase in size.1 The
vast majority of these tumours are 2–6 cm in size
when resected.2 Large tumours often form a single
but irregularly nodular mass which stretches the
overlying skin or mucosa.1 The weight of the tu-
mour can vary from several grams to more than 8
kg5 and the weight appears to increase with the
duration of the tumour. In our case the resected
tumour was 20 cm · 14 cm · 12 cm in dimensions
and the weight of the excised specimen was 3.5 kg.
In a review of 31 giant PAs occurring in the
parotid gland over a period of 140 years by Schultz-
Coulon in 1989, most occurred in females (64.5%)
and only 35.5% occurred in males6 which is con-
sistent with the gender variation of other salivary
gland tumours (except Warthins tumour) and par-
ticularly with that of PA. 1 The age of first tumour
manifestation varied between 20 and 40 years.
However, paediatric patients could also be af-
fected.7 Our patient was a 76-year-old male who
had noticed the gradually enlarging swelling for a
period of more than 30 years. The weight of the
giant tumours reviewed by Schultz-Coulon varied
between 1–26.5 kg.6 The PA in our patient was at
the lower end of this scale.
Malignant changes can occur in PA and include
three distinct pathologic entities: Carcinoma aris-
ing in PA, carcinosarcoma and benign metastasizing
PA.1 Development of secondary carcinoma in PA in
preexisting PA is 3–4% according to the literature.8
Malignant changes were found in only 10% (n ¼ 3)
of the giant PA cases reviewed by Schultz-Coulon.6
The incidence of malignancy frequently shows a
correlation between the length of the history of PA
and the development of a carcinoma.8 It has been
reported that the risk of development of malig-
nancy is only about 1.5% up to 5 years but increases
to 9.5% after more than 15 years.9 The usual pre-
senting symptom of carcinoma arising in PA is a
slowly growing mass which has been present for a
long time, with the average duration of 23 years.10
However, in other series, 45% of carcinomas arising
in PAs were present for less than 3 years. In the
series reported by Spiro et al, some tumours had
been present for 2 years or less.11 Generally,
malignant transformation can be suspected with a
sudden change in growth and local signs of malig-
nancy including pain, ulceration, spontaneous
bleeding, and superficial and deep tissue inva-
sion.10 Furthermore, multiple recurrences and the
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transformation of PA. The clinical characteristics
of malignant transformation have been reported in
the literature as (1) a long history of PA, (2) ad-
vanced age, (3) location in a major salivary gland
and (4) history of rapid growth associated with pain
or ulceration.12 Our patient had all the above
clinical characteristics of malignant transforma-
tion, except a history of rapid growth associated
with pain. However, histopathology showed no
evidence of malignant changes.
In conclusion, untreated PAs can enlarge grad-
ually up to several kilograms in weight. These giant
PAs are more common in females and may enlarge
over a period of several decades. Some of these
long standing tumours show malignant changes.
Therefore, early diagnosis and treatment of PA is
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